Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05469438 · ClinicalTrials.gov registry record
IMAS Optimization and Applicability in Acute and Subacute Stroke.
A clinical trial, sponsored by Case Western Reserve University.
- Completed
- Registry status
- 30
- Enrollment target
NCT05469438: Completed study, sponsored by Case Western Reserve University.
NCT05469438 is a clinical trial that has completed, run by Case Western Reserve University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05469438 has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The investigator will investigate our Integrated sensor-based Motion Analysis Suite (IMAS) to objectively and quantitatively measure acute stroke patient motor status.
Primary Outcome
The coefficient of determination (R²) quantifies how well the predictive model explains variance in Fugl-Meyer Upper Extremity recovery scores. This unitless measure ranges from -∞ to 1, with higher values indicating better model fit (i.e. better prediction). Additional Detail: A sensor suite assessed movement kinematics (e.g., time, position, velocity), and software predicted recovery from baseline characteristics. We report R² for the best-performing model predicting end-of-study FM score fro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-10-29 |
| Est. Completion | 2025-09-30 |
What the finished NCT05469438 record still lists
NCT05469438 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05469438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05469438 about?
NCT05469438 is a clinical study titled "IMAS Optimization and Applicability in Acute and Subacute Stroke.". The investigator will investigate our Integrated sensor-based Motion Analysis Suite (IMAS) to objectively and quantitatively measure acute stroke patient motor status.
What is the current status of trial NCT05469438?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-10-29. Estimated completion is 2025-09-30.
Who is sponsoring clinical trial NCT05469438?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI